BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chew I, Oliva E. Endometrial stromal sarcomas: a review of potential prognostic factors. Adv Anat Pathol 2010;17:113-21. [PMID: 20179433 DOI: 10.1097/PAP.0b013e3181cfb7c2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Borella F, Bertero L, Cassoni P, Piovano E, Gallio N, Preti M, Cosma S, Ferraioli D, Pace L, Mariani L, Biglia N, Benedetto C. Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers. Front Oncol 2022;12:883344. [DOI: 10.3389/fonc.2022.883344] [Reference Citation Analysis]
2 Mayr D, Horn L, Hiller GGR, Höhn AK, Schmoeckel E. Endometriale und weitere seltene uterine Sarkome. Pathologe 2022;43:183-195. [DOI: 10.1007/s00292-022-01072-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 2019;79:1043-60. [PMID: 31656317 DOI: 10.1055/a-0882-4116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
4 Koizumi S, Kamisawa T, Kuruma S, Chiba K, Kikuyama M. IgG4-Related Disease. Rare Rheumatic Diseases of Immunologic Dysregulation 2019. [DOI: 10.1007/978-3-319-99139-9_4] [Reference Citation Analysis]
5 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
6 Billingsley CC, Eisenhauer EL. Uterine Sarcoma. Gynecologic Care 2018. [DOI: 10.1017/9781108178594.034] [Reference Citation Analysis]
7 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
8 Braun T, Henrich W, Knabl J, Kainer F, Faber R, Pauluschke-fröhlich J, Kagan K, Abele H, Horn L. Plazentabedingte Blutungen: Pathophysiologie, Diagnostik, Management. Die Plazenta 2018. [DOI: 10.1007/978-3-662-55622-1_8] [Reference Citation Analysis]
9 Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol 2017;41:12-24. [PMID: 27631520 DOI: 10.1097/PAS.0000000000000721] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
10 Adiga CP, Gyanchandani M, Goolahally LN, Itagi RM, Kalenahalli KV. Endometrial stromal sarcoma: An aggressive uterine malignancy. J Radiol Case Rep 2016;10:35-43. [PMID: 27761197 DOI: 10.3941/jrcr.v10i9.2770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
11 Davidson B, Kjæreng ML, Førsund M, Danielsen HE, Kristensen GB, Abeler VM. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma. Am J Clin Pathol 2016;145:449-58. [PMID: 27149024 DOI: 10.1093/ajcp/aqw030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
12 Denschlag D, Thiel FC, Beckmann MW, Mallmann P. Heterogene Malignome erfordern differenzierte Therapiestrategien. Im Focus Onkologie 2016;19:44-51. [DOI: 10.1007/s15015-016-2279-6] [Reference Citation Analysis]
13 Denschlag D, Thiel FC, Beckmann MW, Mallmann P. Heterogene Malignome erfordern differenzierte Therapiestrategien. gynäkologie + geburtshilfe 2016;21:25-32. [DOI: 10.1007/s15013-016-0846-8] [Reference Citation Analysis]
14 Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P, Strauss HG, Ulrich U, Horn LC, Schmidt D, Vordermark D, Vogl T, Reichardt P, Gaß P, Gebhardt M, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd 2015;75:1028-42. [PMID: 26640293 DOI: 10.1055/s-0035-1558120] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
15 Cuppens T, Tuyaerts S, Amant F. Potential Therapeutic Targets in Uterine Sarcomas. Sarcoma 2015;2015:243298. [PMID: 26576131 DOI: 10.1155/2015/243298] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
16 Romano G. Tumor markers currently utilized in cancer care. MATER METHODS 2015;5. [DOI: 10.13070/mm.en.5.1456] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Sánchez-Ferrer ML, Ferri-Ñíguez B, Schuldt M, Nogales FF. Endometrial stromal nodule of the vaginal wall with a review of vulvovaginal endometrial stromal neoplasms. Gynecol Oncol Rep 2015;11:13-5. [PMID: 26076086 DOI: 10.1016/j.gore.2014.11.003] [Reference Citation Analysis]
18 Beckmann MW, Juhasz-Böss I, Denschlag D, Gaß P, Dimpfl T, Harter P, Mallmann P, Renner SP, Rimbach S, Runnebaum I, Untch M, Brucker SY, Wallwiener D. Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG. Geburtshilfe Frauenheilkd 2015;75:148-64. [PMID: 25797958 DOI: 10.1055/s-0035-1545684] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
19 Baker PM, Oliva E. Prognostic Factors in Uterine Cancer. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_4] [Reference Citation Analysis]
20 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2015. [DOI: 10.1007/978-1-4939-0727-4_27] [Reference Citation Analysis]
21 Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383-93. [PMID: 25299308 DOI: 10.1097/PAP.0000000000000046] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 14.6] [Reference Citation Analysis]
22 Jetley S, Rana S, Jairajpuri ZS. Low grade endometrial stromal sarcoma in a premenopausal woman. J Nat Sci Biol Med 2014;5:214-7. [PMID: 24678233 DOI: 10.4103/0976-9668.127339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Boerkamp KM, Rutteman GR, Kik MJ, Kirpensteijn J, Schulze C, Grinwis GC. Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability. Cancers (Basel) 2012;4:1300-17. [PMID: 24213507 DOI: 10.3390/cancers4041300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Mizuno M, Yatabe Y, Nawa A, Nakanishi T. Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma. Int J Clin Oncol 2012;17:348-54. [PMID: 21830086 DOI: 10.1007/s10147-011-0299-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
25 Lee S, Song JS, Kim G, Choi J, Kim HK, Lee Y, Kim K. Diagnostic Utility of theJAZF1/JJAZ1Gene Fusion in Endometrial Stromal Sarcomas and Their Histologic Variants. Korean J Pathol 2011;45:498. [DOI: 10.4132/koreanjpathol.2011.45.5.498] [Reference Citation Analysis]
26 Tumors of the breast and female genital organs. Modern Immunohistochemistry 2000. [DOI: 10.1017/cbo9781316167366.008] [Reference Citation Analysis]